
[
  {
    "title": "Obsah",
    "chapter_number": "",
    "page_number": "3",
    "children": [
      {
        "title": "Monoklonální protilátky proti cytokinu TNFa – pohled farmakologa",
        "chapter_number": "",
        "page_number": "5",
        "children": []
      },
      {
        "title": "Revmatologie",
        "chapter_number": "",
        "page_number": "",
        "children": [
          {
            "title": "Postavení biologické léčby anti-TNF preparáty v léčbě revmatoidní artritidy",
            "chapter_number": "",
            "page_number": "7",
            "children": []
          }
        ]
      },
      {
        "title": "Dermatologie",
        "chapter_number": "",
        "page_number": "",
        "children": [
          {
            "title": "Postavení biologické léčby v dermatologii",
            "chapter_number": "",
            "page_number": "17",
            "children": []
          },
          {
            "title": "Biologika v dermatologii",
            "chapter_number": "",
            "page_number": "31",
            "children": []
          }
        ]
      },
      {
        "title": "Gastroenterologie",
        "chapter_number": "",
        "page_number": "",
        "children": [
          {
            "title": "Adalimumab v indikaci udržení klinické odezvy a remise u pacientů s Crohnovou chorobou - studie CHARM",
            "chapter_number": "",
            "page_number": "13",
            "children": []
          },
          {
            "title": "Biologická terapie Crohnovy nemoci a ulcerózní kolitidy",
            "chapter_number": "",
            "page_number": "22",
            "children": []
          },
          {
            "title": "Správa zo 16. UEGW 2008 vo Viedni",
            "chapter_number": "",
            "page_number": "38",
            "children": []
          }
        ]
      }
    ]
  }
]
